Page 23 - 《中国药房》2024年10期
P. 23

参考文献                                                    4829-4834.
          [ 1 ]  蔡明远,张翠莲,周亮,等. 全国医疗机构制剂现状调研                  [ 7 ]  王彦芳,陈娟娟,关克磊,等. 医院药师科研能力评价指
              及问题分析[J]. 中国药房,2022,33(5):513-518.                  标体系的构建及其信效度评价[J]. 中国药房,2023,34
              CAI  M  Y,ZHANG  C  L,ZHOU  L,et  al.  Nationwide         (2):242-245.
              investigation  and  problems  analysis  of  pharmaceutical   WANG Y F,CHEN J J,GUAN K L,et al. Construction of
              preparations  in  medical  institutions[J].  China  Pharm,  evaluation  index  system  for  scientific  research  ability  of
              2022,33(5):513-518.                                 hospital  pharmacists  and  analysis  of  its  reliability  and
          [ 2 ]  王雅甜,李超,管志美. 医疗机构传统中药制剂备案管理                       validity[J]. China Pharm,2023,34(2):242-245.
              工作的分析与思考[J]. 中国药房,2022,33(3):263-270.          [ 8 ]  唐密,杨燕,陈珉惺,等. 药品集中带量采购供应企业遴
              WANG Y T,LI C,GUAN Z M. Analysis and reflection on   选多准则决策框架构建[J]. 中南药学,2023,21(8):
              the  filing  management  of  traditional  Chinese  medicine   2219-2223.
              preparations  in  medical  institutions[J].  China  Pharm,  TANG  M,YANG  Y,CHEN  M  X,et  al.  Multi-criteria
              2022,33(3):263-270.                                 decision-making framework for the selection of drug sup‐
          [ 3 ]  吴亚萍. 基于史密斯模型的医疗机构中药制剂备案管理                        ply  enterprises  in  centralized  volume-based  procurement
              政策执行与对策[J]. 中医药管理杂志,2022,30(14):                    [J]. Cent South Pharm,2023,21(8):2219-2223.
              141-143.                                       [ 9 ]  江依帆,陈丽萍,张若钰,等. 抑酸药物的临床综合评价
              WU  Y  P.  Based  on  the  Smith  policy  implementation   指标体系构建[J]. 中国药物评价,2023,40(5):416-421.
              model of medical institutions of traditional Chinese medi‐  JIANG Y F,CHEN L P,ZHANG R Y,et al. Construction
              cine  preparation  for  the  record  management  policies  and   of  clinical  comprehensive  value  evaluation  system  for
              countermeasures  research[J].  J Tradit  Chin  Med  Manag,  acid-inhibiting drugs[J]. Chin J Drug Eval,2023,40(5):
              2022,30(14):141-143.                                416-421.
          [ 4 ]  罗李娜,陈更新. 医疗机构中药制剂开发模式[J]. 中华中               [10]  李波,王广建. 少弱精子症中西医结合诊疗河北专家共
              医药杂志,2023,38(7):3224-3227.                          识:2022版[J]. 河北中医,2022,44(9):1578-1584.
              LUO  L  N,CHEN  G  X.  Development  mode  of  Chinese   LI B,WANG G J. Hebei experts’ consensus on integrated
              medicine  in  medical  institutions[J].  China  J  Tradit  Chin   traditional  Chinese  and  Western  medicine  for  diagnosis
              Med Pharm,2023,38(7):3224-3227.                     and  treatment  of  oligoasthenozoospermia:2022  version
          [ 5 ]  高敏洁. 人用经验在传统中药制剂备案中的应用情况研                        [J]. Hebei J Tradit Chin Med,2022,44(9):1578-1584.
              究[J]. 中国临床药学杂志,2022,31(5):359-364.             [11]  牟娜,吴斌,邹任贤. 传统中药制剂备案中药学研究常见
              GAO M J. Investigation on the application of human use   问题及对其向中药新药转化的影响分析[J]. 上海医药,
              experience in filing traditional Chinese medicine prepara‐  2023,44(13):12-15.
              tions  for  record[J].  Chin  J  Clin  Pharm,2022,31(5):  MOU  N,WU  B,ZOU  R  X.  Analysis  of  common  pro-
              359-364.                                            blems  in  the  research  of  traditional  Chinese  medicine
          [ 6 ]  杨忠奇,高蕊,胡思源,等. 中药人用经验研究专家共识                       preparations  and  the  impact  on  their  transformation  into
              [J]. 中国中药杂志,2022,47(18):4829-4834.                  new Chinese medicine[J]. Shanghai Med Pharm J,2023,
              YANG Z Q,GAO R,HU S Y,et al. Expert consensus on    44(13):12-15.
              human  use  experience  research  of  traditional  Chinese    (收稿日期:2023-12-14  修回日期:2024-04-12)
              medicine[J].  China  J  Chin  Mater  Med,2022,47(18):                               (编辑:孙 冰)



















          中国药房  2024年第35卷第10期                                              China Pharmacy  2024 Vol. 35  No. 10    · 1173 ·
   18   19   20   21   22   23   24   25   26   27   28